| Net earnings | 26.31M |
| (Income) loss from discontinued operations, net of tax | -15K |
| Depreciation and amortization | 39.65M |
| Amortization of deferred gain from asset sales | -6.3M |
| Stock compensation expense | 1.91M |
| Deferred income taxes | 4.24M |
| Net gain from disposition of assets | -86K |
| Loss from asset impairment | 389K |
| Other | 272K |
| Decrease in accounts receivable, prepaid expenses and other | 21.82M |
| (Increase) decrease in merchandise inventories | -12.92M |
| Increase (decrease) in accounts payable | 12.04M |
| Decrease in accrued expenses | -33.2M |
| (Decrease) increase in other long-term liabilities | -2.83M |
| Net cash provided by continuing operations | 51.28M |
| Net cash used in discontinued operations | -44K |
| Net cash provided by operating activities | 51.23M |
| Capital expenditures | -30.64M |
| Proceeds from dispositions of assets | 89K |
| Premiums paid on life insurance policies | -795K |
| Collateral investment | -4.76M |
| Acquisitions, net of cash acquired | -42.76M |
| Net cash used in continuing operations | -78.86M |
| Net cash provided by discontinued operations | 0 |
| Net cash used in investing activities | -78.86M |
| Borrowings under line of credit agreements | 5.05M |
| Payments under line of credit agreements | -5.05M |
| Borrowings on trade payable program liability | 59.1M |
| Payments on trade payable program liability | -53.94M |
| Payment for finance issuance cost | -2.44M |
| Debt payments | -539K |
| Dividends paid | -3.17M |
| Other | 363K |
| Net cash (used in) provided by financing activities | -635K |
| Net (decrease) increase in cash and cash equivalents | -28.26M |
| Cash and cash equivalents at beginning of period | 90.24M |
| Cash and cash equivalents at end of period | 61.98M |
| Cash paid for income taxes | 629K |
| Cash paid for interest | 11.52M |
| Accrued purchases of property and equipment | 1.42M |